Sofgen Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	256	264	459	592	1,100	260
Market Cap Growth	-13.07%	-42.51%	-22.48%	-46.15%	323.09%	8.29%
Enterprise Value	532	535	731	818	1,220	-
Last Close Price	0.11	2.34	4.07	5.25	9.75	10.40
PE Ratio	-	-	11.38	16.40	-	-
Forward PE	-	4.79	14.09	12.21	-	-
PS Ratio	0.68	0.71	1.08	1.47	2.73	0.78
PB Ratio	-4.91	-5.07	-623.90	-15.95	-15.72	-1.02
P/FCF Ratio	3.71	3.82	5.26	-	54.96	4.11
P/OCF Ratio	2.89	2.99	4.27	38.09	31.03	3.67
PEG Ratio	-	0.32	0.32	0.29	-	-
EV/Sales Ratio	1.42	1.43	1.72	2.03	3.02	-
EV/EBITDA Ratio	-	-	10.48	18.30	669.77	-
EV/EBIT Ratio	-	-	11.93	23.98	-	-
EV/FCF Ratio	7.70	7.75	8.37	-	60.93	-
Debt / Equity Ratio	-5.89	-5.89	-424.80	-8.09	-3.62	-1.78
Debt / EBITDA Ratio	-	-	4.12	5.89	41.92	5.71
Debt / FCF Ratio	4.44	4.44	3.58	-	12.66	7.19
Net Debt / Equity Ratio	-5.31	-5.31	-401.00	-6.93	-2.59	-1.77
Net Debt / EBITDA Ratio	-14.45	-14.45	4.23	5.75	99.54	6.01
Net Debt / FCF Ratio	4.00	4.00	3.38	-33.81	9.06	7.12
Asset Turnover	0.85	0.85	0.93	0.90	1.00	0.95
Inventory Turnover	2.04	2.04	1.84	1.85	2.39	2.17
Quick Ratio	0.29	0.29	0.36	0.42	0.55	0.47
Current Ratio	0.52	0.52	0.64	0.72	0.80	0.77
Return on Assets (ROA)	-4.03%	-4.03%	8.37%	4.78%	-1.40%	11.30%
Return on Invested Capital (ROIC)	-10.98%	-10.98%	20.90%	15.58%	-5.91%	-419.33%
Return on Capital Employed (ROCE)	673.10%	673.10%	157.30%	60.70%	-9.60%	52.60%
Earnings Yield	-26.68%	-25.87%	8.79%	6.10%	-9.73%	-4.02%
FCF Yield	26.97%	26.16%	19.01%	-1.28%	1.82%	24.32%
Buyback Yield / Dilution	0.83%	0.73%	0.10%	-3.02%	-1.04%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.